ClinicalTrials.gg
Sign In

Scorpion Therapeutics clinical trials

Acquired by Eli Lilly and Company, Mar 2025 · source ↗

The registry lists 3 studies whose lead sponsor is Scorpion Therapeutics. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 9, 2026.

Before and after it joined Eli Lilly and Company

First submitted before Scorpion Therapeutics became part of Eli Lilly and Company
0
First submitted after Scorpion Therapeutics became part of Eli Lilly and Company
2
Unclear, or no submission date
1

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Scorpion Therapeutics’s studies test, most open studies first — 1 drug with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Scorpion Therapeutics’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. 1A
  11. S
  12. O
  13. N

The study

Add it to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered1

All 3 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now133%
  • Completed267%

Phase

  • Phase 13

Where

  • United States3

Over the years

  1. 225
  2. 126

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company3 studies

Something wrong with this grouping? Tell us on the Eli Lilly and Company page.

Studies

Recruiting first, then most recently updated. Showing 3 of 3. All Eli Lilly and Company studies →